首页 › 股票 › LSB

LSB — LAKESHORE BIOPHARMA CO LTD

申报持仓市值$4.01M
持有基金数(最新)16
板块—

什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

HoldingsHub 追踪了 LSB(LAKESHORE BIOPHARMA CO LTD)近五年的季度 13F 申报数据。历史上有 16 家基金申报过持仓,其最近一期申报市值合计 $4.01M。最新季度无机构披露持仓,通常意味着该股已退出追踪基金的组合,而非不可投资。

LAKESHORE BIOPHARMA CO LTD(LSB)的主要机构持有人包括 ORBIMED ADVISORS LLC、Valliance Asset Management Ltd、Fidelity Management & Research (FMR),按 13F 申报市值在本页 16 家持有人中排名居前。

本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。

机构逐季持仓趋势

季度 持有机构数 股数 金额 环比净变动
Q3 2024 7 3.23M $2.23M -9.1%
Q2 2024 11 5.12M $3.34M -12.3%
Q1 2024 8 5.32M $3.79M -35.2%
Q4 2023 10 9.33M $4.89M -16.8%
Q3 2023 9 10.79M $8.63M -0.3%
Q2 2023 5 4.66M $6.43M +0.0%
Q1 2023 5 4.67M $7.44M —

表内 7 个季度中,机构持股合计减少 31%(Q1 2023 → Q3 2024);单季变动最大的是 Q1 2024(-35.2%)。

前 25 大机构持仓人(Q3 2024) — 7 家基金

基金股数金额组合权重变化
Fidelity Management & Research (FMR) 1.17M $802.73K 0.00% 持有
Hillhouse Capital (HHLR Advisors) 751.79K $512.72K 0.01% 持有
Fidelity International (FIL) 615.48K $424.06K 0.00% 减持
SUPERSTRING CAPITAL MANAGEMENT LP 307.92K $212.16K 0.21% 持有
BARCLAYS PLC 247.57K $168.85K 0.00% 持有
BANK OF MONTREAL /CAN/ 93.81K $75.52K 0.00% 减持
UBS Group AG 49.42K $33.70K 0.00% 新进

↑ 返回持仓列表顶部

更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人

Q2 2024 — 11 家基金

基金股数金额组合权重变化
ORBIMED ADVISORS LLC 1.40M $909.83K 0.02% 减持
Fidelity Management & Research (FMR) 1.17M $754.85K 0.00% 持有
Hillhouse Capital (HHLR Advisors) 751.79K $487.08K 0.01% 持有
Fidelity International (FIL) 733.42K $475.19K 0.00% 减持
BANK OF MONTREAL /CAN/ 292.70K $295.63K 0.00% 减持
SUPERSTRING CAPITAL MANAGEMENT LP 307.92K $199.50K 0.25% 持有
BARCLAYS PLC 247.57K $160.40K 0.00% 新进
Citadel Advisors 40.67K $26.35K 0.00% 新进
Ovata Capital Management Ltd 150.00K $10.21K 0.01% 新进
Geode Capital Management 13.61K $8.82K 0.00% 持有
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11.67K $7.56K 0.00% 新进

Q1 2024 — 8 家基金

基金股数金额组合权重变化
ORBIMED ADVISORS LLC 1.53M $1.10M 0.02% 减持
Fidelity International (FIL) 1.20M $843.33K 0.00% 减持
Fidelity Management & Research (FMR) 1.17M $815.55K 0.00% 持有
Hillhouse Capital (HHLR Advisors) 751.79K $526.25K 0.01% 持有
BANK OF MONTREAL /CAN/ 344.12K $275.26K 0.00% 新进
SUPERSTRING CAPITAL MANAGEMENT LP 307.92K $215.54K 0.14% 持有
Geode Capital Management 13.61K $9.53K 0.00% 持有
WOLVERINE ASSET MANAGEMENT LLC 499 $359 0.00% 持有

Q4 2023 — 10 家基金

基金股数金额组合权重变化
ORBIMED ADVISORS LLC 3.24M $1.65M 0.03% 减持
Fidelity International (FIL) 2.20M $1.18M 0.00% 减持
Valliance Asset Management Ltd 1.61M $821.27K 29.03% 持有
Fidelity Management & Research (FMR) 1.17M $626.81K 0.00% 持有
Hillhouse Capital (HHLR Advisors) 751.79K $404.46K 0.01% 持有
SUPERSTRING CAPITAL MANAGEMENT LP 307.92K $165.66K 0.12% 新进
Citadel Advisors 42.85K $23.06K 0.00% 新进
Geode Capital Management 13.61K $7.32K 0.00% 持有
WOLVERINE ASSET MANAGEMENT LLC 499 $254 0.00% 持有
Tower Research Capital LLC (TRC) 4 $2 0.00% 减持

Q3 2023 — 9 家基金

基金股数金额组合权重变化
ORBIMED ADVISORS LLC 4.54M $3.63M 0.08% 新进
Fidelity International (FIL) 2.71M $2.16M 0.00% 持有
Valliance Asset Management Ltd 1.61M $1.29M 4.68% 新进
Fidelity Management & Research (FMR) 1.17M $932.06K 0.00% 持有
Hillhouse Capital (HHLR Advisors) 751.79K $601.43K 0.01% 持有
Geode Capital Management 13.61K $10.89K 0.00% 持有
BARCLAYS PLC 5.69K $4.55K 0.00% 新进
WOLVERINE ASSET MANAGEMENT LLC 499 $399 0.00% 新进
Tower Research Capital LLC (TRC) 221 $177 0.00% 新进

Q2 2023 — 5 家基金

基金股数金额组合权重变化
Fidelity International (FIL) 2.72M $3.75M 0.00% 持有
Fidelity Management & Research (FMR) 1.17M $1.61M 0.00% 持有
Hillhouse Capital (HHLR Advisors) 751.79K $1.04M 0.02% 持有
Geode Capital Management 13.61K $18.78K 0.00% 持有
UBS Group AG 7.05K $9.73K 0.00% 新进

新建仓(最新)

本季度没有基金新建该仓位。

完全清仓(较上季)

本季度没有被追踪基金完全清仓。

基金持仓历史 — 各季度股数(前 16 只基金)

基金Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023
Fidelity Management & Research (FMR) 1.17M 1.17M 1.17M 1.17M 1.17M 1.17M 1.17M
Hillhouse Capital (HHLR Advisors) 751.79K 751.79K 751.79K 751.79K 751.79K 751.79K 751.79K
Fidelity International (FIL) 615.48K 733.42K 1.20M 2.20M 2.71M 2.72M 2.72M
SUPERSTRING CAPITAL MANAGEMENT LP 307.92K 307.92K 307.92K 307.92K — — —
BARCLAYS PLC 247.57K 247.57K — — 5.69K — —
BANK OF MONTREAL /CAN/ 93.81K 292.70K 344.12K — — — —
UBS Group AG 49.42K — — — — 7.05K —
ORBIMED ADVISORS LLC — 1.40M 1.53M 3.24M 4.54M — —
Valliance Asset Management Ltd — — — 1.61M 1.61M — —
Citadel Advisors — 40.67K — 42.85K — — —
Geode Capital Management — 13.61K 13.61K 13.61K 13.61K 13.61K 13.61K
Ovata Capital Management Ltd — 150.00K — — — — —
SUSQUEHANNA INTERNATIONAL GROUP, LLP — 11.67K — — — — —
WOLVERINE ASSET MANAGEMENT LLC — — 499 499 499 — —
Tower Research Capital LLC (TRC) — — — 4 221 — —
Millennium Management — — — — — — 23.09K

下载持有人名单 (CSV)

常见问题

Which funds hold LSB?

16 funds have reported positions in LSB across five years of 13F filings; the sum of their latest reported stakes is $4.01M.

Who are the top institutional holders of LSB?

The largest 13F holders are ORBIMED ADVISORS LLC, Valliance Asset Management Ltd, Fidelity Management & Research (FMR), Hillhouse Capital (HHLR Advisors), Fidelity International (FIL); the top 25 are ranked at the top of this page.

Who are the major shareholders of LAKESHORE BIOPHARMA CO LTD?

The major shareholders of LAKESHORE BIOPHARMA CO LTD (LSB) by reported 13F value are ORBIMED ADVISORS LLC, Valliance Asset Management Ltd, Fidelity Management & Research (FMR), Hillhouse Capital (HHLR Advisors), Fidelity International (FIL), among 16 institutional holders.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.

将本股票嵌入你的网站

复制下面的代码,即可在你的博客或论坛上展示「哪些传奇投资人持有 LSB」的实时名单——免费、自动更新、回链 HoldingsHub。

<iframe src="https://holdingshub.top/stocks/LSB/widget" width="100%" height="640" frameborder="0" loading="lazy" title="HoldingsHub stock holders"></iframe>

预览可嵌入组件 →